The Cost in Oxygen of Surgical Trauma

Status Completed

Clinical Trial Summary

The investigators will examine the relationship between post-operative oxygen consumption (using non-invasive measurement technology ) and complications in patients having contemporary major abdominal surgery. The investigators hypothesis is that major surgery may trigger a physiological stress response that results in an increase in post-operative metabolic demand and oxygen consumption (V̇O2) which must be met by an increased oxygen delivery (DO2).

1. To determine the feasibility of non-invasive measurement of oxygen consumption (V̇O2) using indirect calorimetry in a cohort of patients

2. To determine the feasibility of non-invasive measurement of oxygen delivery (DO2) in the same cohort using non-invasive measures of cardiac output, oxygen saturation and haemoglobin (pulse wave transit time and co-oximetry techniques)

Clinical Trial Description

Prospective observational study of non-invasive measurements of V̇O2 and DO2 pre-operatively and at 8 time points in the 48 hours postoperatively in a cohort of 40 patients undergoing elective major abdominal surgery (both open and laparoscopic) with a pre-operative cardiopulmonary exercise testing (CPET).

As pilot work examining the relationship between post-operative oxygen consumption and complications in patients having contemporary major abdominal surgery , the investigators need to define and grade the severity of complications. The Post-Operative Morbidity Survey (POMS) is a simple outcome scale designed to record the incidence of clinically important complications - specifically complications likely to keep a patient in hospital. A POMS score performed on Day 5 is likely to be discriminative between patients who are recovering well, and those who are developing complications. POMS is easily performed, has good internal validity and is predictive of a prolonged length of stay. POMS is not a simple additive scale; however patients with POMS score of 1 or greater are highly likely to remain in hospital, whereas those with a score of 0 are likely to be able to go home. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02238561
Study type	Observational
Source	Plymouth Hospitals NHS Trust
Contact
Status	Completed
Phase	N/A
Start date	November 2014
Completion date	August 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02571400` - Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort Study	N/A
Not yet recruiting	`NCT02096640` - Postoperative Inflammation and Recovery After Tracheostomy	N/A
Suspended	`NCT01998815` - Role and Mechanisms of Obesity Surgery
Completed	`NCT02438293` - 'The Impact of Rhinovirus Infections in Paediatric Cardiac Surgery'
Unknown status	`NCT00665587` - AMAZING PRAGUE (PRAGUE-12)	N/A
Enrolling by invitation	`NCT00606372` - On-Pump vs. Off-Pump CABG in High-Risk Patients (EuroSCORE 6+)	N/A
Recruiting	`NCT03643718` - Web-based International Register of Emergency Surgery and Trauma
Completed	`NCT02659553` - Impact of Graft Steatosis on Post-operative Complications After Liver Transplantation	N/A
Completed	`NCT01801813` - Risk Factors of Complications Regarding Patients Undergoing Brain Tumour Neuro-surgery (Cranioscore).	N/A
Completed	`NCT01137084` - Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids	N/A
Recruiting	`NCT04892901` - Erector Spinae Plane Block in Uniportal VATS
Completed	`NCT03551899` - Intra-operative Ventilatory Management & Post-operative Pulmonary Complications
Completed	`NCT01450631` - The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.